Literature DB >> 30980867

Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation.

Lu Gao1, Gang Lv2, Rong Li1, Wen-Ting Liu1, Chen Zong1, Fei Ye1, Xiao-Yong Li1, Xue Yang1, Jing-Hua Jiang1, Xiao-Juan Hou1, Ying-Ying Jing1, Zhi-Peng Han3, Li-Xin Wei4.   

Abstract

Metastasis and recurrence severely impact the treatment effect of hepatocellular carcinoma (HCC). HCC complicated with cholestasis is more prone to recurrence and metastasis. Previous studies have implicated pathogenesis of HCC by bile acid; however, the underlying mechanism is unknown yet. Glycochenodeoxycholate (GCDC) is one of most important component of bile acid (BA). In the present study, the role of GCDC in HCC cells invasion was detected by in vitro and in vivo assays. GCDC was found to significantly enhance the invasive potential of HCC cells; Further studies showed that GCDC could induce autophagy activation and higher invasive capability in HCC cells. Interestingly, inhibition of autophagy by chloroquine (CQ) reversed this phenomenon. Subsequently, the correlation between TBA expression level and clinicopathological characteristics was analyzed in HCC patients. Clinically, high TBA level in HCC tissue was found to be associated with more invasive and poor survival in HCC patients. Mechanistic study showed that bile acid induced autophagy by targeting the AMPK/mTOR pathway in HCC cells. Therefore, our results suggest that bile acid may promote HCC invasion via activation of autophagy and the level of bile acid may serve as a potential useful indicator for prognosis of HCC patients.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Cholestasis; Hepatocellular carcinoma; Metastasis

Year:  2019        PMID: 30980867     DOI: 10.1016/j.canlet.2019.04.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

Review 1.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

2.  Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells.

Authors:  Chun Gao; Long Fang; Hui Zhang; Wei-Shuo Zhang; Xiao-Ou Li; Shi-Yu Du
Journal:  Cancer Manag Res       Date:  2020-07-14       Impact factor: 3.989

Review 3.  Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.

Authors:  Jiao Feng; Jingjing Li; Liwei Wu; Qiang Yu; Jie Ji; Jianye Wu; Weiqi Dai; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2020-07-06

Review 4.  Macrophages and hepatocellular carcinoma.

Authors:  Zhiqiang Tian; Xiaojuan Hou; Wenting Liu; Zhipeng Han; Lixin Wei
Journal:  Cell Biosci       Date:  2019-09-26       Impact factor: 7.133

5.  The Sonic Hedgehog signaling pathway regulates autophagy and migration in ovarian cancer.

Authors:  Yibin Pan; Jiena Zhou; Weidan Zhang; Lili Yan; Meifei Lu; Yongdong Dai; Hanjing Zhou; Songying Zhang; Jianhua Yang
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

6.  Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer.

Authors:  Su Liu; Chao Yue; Huanqiu Chen; Yun Chen; Gang Li
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

7.  Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB.

Authors:  Zuotian Huang; Tong Mou; Yunhai Luo; Xingyu Pu; Junliang Pu; Lei Wan; Junhua Gong; Hang Yang; Yanyao Liu; Zhongtang Li; Ai Shen; Zhongjun Wu
Journal:  Cell Death Dis       Date:  2020-06-12       Impact factor: 8.469

8.  Kindlin‑2 suppresses cervical cancer cell migration through AKT/mTOR‑mediated autophagy induction.

Authors:  Guangteng Wu; Ying Long; Yan Lu; Yiming Feng; Xinmei Yang; Xun Xu; Desheng Yao
Journal:  Oncol Rep       Date:  2020-05-04       Impact factor: 3.906

Review 9.  The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases.

Authors:  Haojie Wang; Yumei Liu; Dongmei Wang; Yaolu Xu; Ruiqi Dong; Yuxiang Yang; Qiongxia Lv; Xiaoguang Chen; Ziqiang Zhang
Journal:  Cells       Date:  2019-12-09       Impact factor: 6.600

10.  Cudraxanthone D Regulates Epithelial-Mesenchymal Transition by Autophagy Inhibition in Oral Squamous Cell Carcinoma Cell Lines.

Authors:  Su-Bin Yu; Hae-Mi Kang; Dan-Bi Park; Bong-Soo Park; In-Ryoung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.